We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Barely two months after scoring an FDA nod, Senseonics’ long-term continuous glucose monitor is hitting the market. It is now available in clinics across the U.S.